• Explore /
  • Poster
  • / Effectiveness and safety of pazopanib (PAZO) and everolimus (EVE) in a changing treatment (Tx) landscape: Interim results of the non-interventional study PAZOREAL.

Effectiveness and safety of pazopanib (PAZO) and everolimus (EVE) in a changing treatment (Tx) landscape: Interim results of the non-interventional study PAZOREAL.

Abstract Poster

Authors

null

Martin Boegemann

University of Muenster Medical Center, Münster, Germany

Martin Boegemann , Jens Bedke , Martin Schostak , Manfred Welslau , Christiane Hering-Schubert , Thomas Wolf , Jan Schleicher , Alexander Petzold , Christian Doehn , Carsten Grüllich , Viktor Grünwald , Thomas Steiner , Rainer Ehness , Dunja Klein , Tanja Medinger , Peter-Juergen Goebell

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Genitourinary (Nonprostate) Cancer

Track

Genitourinary Cancer—Kidney and Bladder

Sub Track

Kidney Cancer

Citation

J Clin Oncol 36, 2018 (suppl; abstr 4584)

DOI

10.1200/JCO.2018.36.15_suppl.4584

Abstract #

4584

Poster Bd #

410

Abstract Disclosures

Similar Posters

First Author: Shaan Dudani

First Author: Martin Schostak

First Author: Jose Manuel Ruiz Morales

First Author: Giuseppe Procopio